Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents

Neuromuscular Disorders

Volumn 8, Issue 3-4, 1998, Pages 186-192

  Deconinck, N ^a,b   Van Parijs, V ^b   Beckers Bleukx, G ^a   Van Den Bergh, P ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Critical illness; Myopathy; Myosin

Indexed keywords

CORTICOSTEROID; MYOSIN; NEUROMUSCULAR BLOCKING AGENT;

ACUTE LEUKEMIA; ADULT; AGED; ANOXIA; ARTIFICIAL VENTILATION; BIOCHEMISTRY; CASE REPORT; COMA; CONFERENCE PAPER; CRITICAL ILLNESS; ELECTROPHYSIOLOGY; FEMALE; HUMAN; INTENSIVE CARE; MALE; MULTIPLE ORGAN FAILURE; MUSCLE BIOPSY; MYOPATHY; PRIORITY JOURNAL; QUADRIPLEGIA; RESPIRATORY DISTRESS; SEPSIS; SURGERY;

ACTINS; AGED; BIOPSY; CRITICAL ILLNESS; ELECTRODIAGNOSIS; FEMALE; HUMANS; MALE; MICROFILAMENTS; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOSINS;

EID: 0032078713     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00003-0     Document Type: Conference Paper

References (31)

1. Bolton C.F., Gilbert J.J., Hahn A.F., Sibbald W.J. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 47:1984;1223-1231.
2. Zochodne D.W., Bolton C.F., Wells G.A. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain. 110:1987;819-842.
3. Witt N.J., Zochodne D.W., Bolton C.F.et al. Peripheral nerve function in sepsis and multiple organ failure. Chest. 99:1991;176-184.
4. Bolton C.F., Young G.B., Zochodne D.W. The neurological complications of sepsis. Ann Neurol. 33:1993;94-100.
5. Segredo V., Matthay M.A., Sharma M.L.et al. Prolonged neuromuscular blockade after long term administration of vecuronium in two critically ill patients. Anesthesiology. 72:1990;566-570.
6. Partridge B.L., Abroms J.H., Basemore C., Rubin R. Prolonged neuromuscular blockade after long-term administration of vecuronium bromide in the intensive care unit. Crit Care Med. 18:1990;1177-1179.
7. Kupfer Y., Namba T., Kaldawi E., Tessler S. Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med. 117(6):1992;484-486.
8. MacFarlane I.A., Rosenthal F.D. Severe myopathy after status asthmaticus. Lancet. 2:1977;615.
9. Ramsay D.A., Zochodne D.W., Robertson D.M., Nag S., Ludwin S.K. A syndrome of acute severe muscle necrosis in intensive care unit in patients. J Neuropathol Exp Neurol. 52:1993;387-398.
10. Zochodne D.W., Ramsay D.A., Saly V., Shelley S., Moffat S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve. 17:1994;285-292.
11. Sher J.H., Shafiq S.A., Schutta H.S. Acute myopathy with selective lysis of myosin filaments. Neurology. 29:1979;100-106.
12. Danon M.J., Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve. 14:1991;1131-1139.
13. Hirano M., Ott B.R., Raps E.C.et al. Acute quadriplegic myopathy: a complication of treatment with steroids, non depolarizing blocking agents, or both. Neurology. 42:1992;2082-2087.
14. Lacomis D., Giuliani M.J., Van Cott A., Kramer D.J. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol. 40:1996;645-654.
15. Rouleau G., Karpati G., Carpenter S., Soza M., Prescott S., Holland P. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve. 10:1987;428-438.
16. Murakami U., Uchida K. Contents of myofibrillar proteins in cardiac, skeletal and smooth muscles. J Biochem. 98:1985;187-197.
17. Latronico N., Fenzi F., Recupero D.et al. Critical illness myopathy and neuropathy. Lancet. 347:1996;1579-1582.
18. Lacomis D., Smith T.W., Chad D.A. Acute myopathy and neuropathy in status asthmaticus: case report and literature review. Muscle Nerve. 16:1993;84-90.
19. Showalter C.J., Engel A.G. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve. 20:1997;316-322.
20. Carpenter S, Karpati G. Pathology of skeletal muscle. New York: Churchill Livingstone, 1984:220-221.
21. Gonzales M.F., Olney R.K., So Y.T.et al. Subacute stuctural myopathy associated with human immunodeficiency virus infection. Arch Neurol. 45:1988;585-587.
22. Yarom R., Shapira Y. Myosin degeneration in a congenital myopathy. Arch Neurol. 34:1977;114-115.
23. Massa R., Carpenter S., Holland P., Karpati G. Loss and renewal of thick filaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve. 15:1992;1290-1298.
24. Buchtal F. Electrophysiological abnormalities in metabolic myopathies and neuropathies. Acta Neurol Scand. 46:1970;129-176.
25. Layzer RB. Neuromuscular manifestations of systemic disease. Philadelphia: F.A. Davis, 1985:319-362.
26. Ruff R.L., Secrist D. Inhibitors of prostaglandin synthesis or cathepsin B prevent muscle wasting due to sepsis in the rat. J Clin Invest. 73:1984;1483-1486y.
27. Mitch W.E., Goldberg A.L. Mechanisms of muscle wasting. The role of the ubiquitine proteasome pathway. N Engl J Med. 335:1996;1897-1905.
28. Zamir O., O'Brien W., Thompson R.et al. Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. Int J Biochem. 26:1994;943-950.
29. Breuille D., Forge M.C., Rose F.et al. Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis. Am J Physiol. 265:1993;E660-666.
30. Clowes G.H.A., George B.C., Villee C.A., Saravis C.A. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med. 308:1983;545-552.
31. Baracos V., Rodemann H.P., Dinarello C.A., Goldberg A.L. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). N Engl J Med. 308:1983;553-558.